News for Mesoblast Limited (MSB.AX)

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Friday. Shares of Booz Allen Hamilton Holding Corporation BAH fell sha...

S&P 500 and Nasdaq rebound 9% and 11% respectively. Australian pharmaceuticals, CSL Limited look to rebound strongly.

If you thought a 104% tariff on China was bad enough, Trump’s…

The ASX has been down 1.5% at 7,739 points this morning. There’s…

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provid

**media[584512]**

**media[580803]**

The ASX has been down 0.55% at 7,956 points on Thursday so…

Mesoblast (ASX:MSB) has announced its product Ryoncil is officially available for sale in the US through private health insurance.

**media[577836]**

NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, toda

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, anno

**media[564251]**

Good afternoon and welcome to HotCopper’s Market Close, I’m Jonathon Davidson. The…

Good Afternoon and welcome to the weekly HotCopper Highlights wrap for Week 10, I’m Jonathon Davidson. Let’s get into it.

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its addition to the S&P Dow Jones

Welcome to this week’s HotCopper market-watch podcast! Each week, HotCopper’s senior markets…

Another depressing day for Oz. The culprit? Wall Street's worst night YTD, OPEC+ output boost, iron ore tumble and Trump.

Mesoblast Limited (NASDAQ:MESO) Q2 2025 Earnings Conference Call February 26, 2025 5:00 PM ETCompany ParticipantsSilviu Itescu - Chief Executive Officer...